Why You Deserve More Answers After a Miscarriage
You've had a miscarriage. Maybe more than one. And you've been told to keep trying.
Perhaps it was said kindly. Perhaps your doctor patted your hand and explained that miscarriage is very common: that one in four pregnancies ends this way, that it's usually "just one of those things," that your body will sort itself out. Perhaps they told you to give it a few months and come back if it happens again.
And so you went home with your grief, your questions, and no answers.
This is a clinical problem. And it's one I see in practice regularly.
"Common" Does Not Mean Uninvestigable
Miscarriage is common. That is true. But common does not mean inevitable. And it certainly does not mean uninvestigable.
The fact that something happens to many people is not a reason to stop asking why it happened to you. If anything, it's a reason to take it more seriously. Patterns that show up frequently are exactly the kind that research can illuminate, that investigation can identify, and that support can address.
When we accept "it's common" as a full answer, we close the conversation before it has really begun. And that is where the system fails people.
There are meaningful, investigable factors that contribute to miscarriage. Some are embryonic. Some are maternal. Some (and this is the part that rarely gets said out loud) are on the paternal side. Recurrent miscarriage testing, done well, is not a single blood test and a reassuring follow-up. It is a considered look at both partners, at the pregnancy itself where possible, and at the biological environment in which conception is trying to happen.
"I don't want to chase symptoms. I want to understand the why."
What Investigation on the Female Side Can Include
Standard post-miscarriage workup, when it is offered at all, often covers the basics: clotting factors, a uterine scan, perhaps a hormone panel. This is a starting point, not a destination.
There is more worth asking about. A miscarriage investigation naturopath, working alongside your medical team, can help you map this terrain.
Thyroid function: a full panel, not just TSH in isolation. Thyroid hormones play a direct role in implantation and early pregnancy support. A TSH that sits within "normal" range may still be suboptimal for fertility. Free T3, free T4, and thyroid antibodies are all clinically relevant.
Autoimmune markers: particularly antiphospholipid antibodies, which are associated with recurrent pregnancy loss and increased clotting risk in early pregnancy. This is a well-established area of investigation that is sometimes missed until a third miscarriage has occurred. It should not take three losses to get here.
Natural killer (NK) cell: NK cell activity is another area worth raising. There is emerging evidence around elevated uterine NK cell activity and implantation failure, though this remains an evolving space. It is worth a conversation with a clinician who specialises in recurrent pregnancy loss.
Nutrigenomic factors including methylation: MTHFR is one piece of this picture, and more on that below. But methylation capacity more broadly (the body's ability to process folate, recycle homocysteine, and support cellular repair) is a legitimate clinical consideration in the context of recurrent loss.
Genitourinary microbiome: there is growing evidence that the uterine and vaginal microbiome plays a role in implantation and early pregnancy maintenance. This is not yet standard in routine investigation, but it is worth knowing about and raising with your healthcare team.
None of these are about finding something to blame. All of them are about understanding the environment in which a pregnancy is trying to thrive.
What Investigation on the Male Side Should Include
This is where I need to be direct, because this is where the gap in standard care is significant.
Half of the fertility equation involves him.
A standard semen analysis tells you about sperm count, motility, and morphology. It does not tell you about DNA integrity. Sperm DNA fragmentation and miscarriage have a well-documented relationship: elevated fragmentation compromises embryo development and early pregnancy viability. And yet this test is not routinely included in standard semen analysis.
A sperm sample can pass a standard analysis with flying colours and still carry levels of DNA fragmentation that are clinically significant. This is not fringe science. It has been substantiated in the research for over a decade. It is simply not on the standard checklist. It should be.
If your partner has not had sperm DNA fragmentation testing, it is worth raising with your healthcare team. The question of recurrent pregnancy loss (what to test) is not complete until both partners have been meaningfully assessed.
The Foetal Testing Conversation
Here is something I find genuinely difficult to sit with as a clinician.
When a miscarriage occurs, the pregnancy tissue contains information. Chromosomal analysis of the products of conception can tell us whether a chromosomal abnormality was present, and critically, what kind. That distinction changes everything about where you look next.
IF DIFFERENT CHROMOSOMAL ABNORMALITIES ARE FOUND
If a chromosomal abnormality is found, the next question is whether it is random or patterned. A single trisomy (where there is one extra chromosome) is a relatively common meiotic error, and in isolation it may well be a chance event. But if you have had two or three miscarriages and each one shows a different trisomy (trisomy 16 in one pregnancy, trisomy 22 in the next), that pattern of different random errors can point toward the quality of the eggs or sperm at the time of conception. Oxidative stress, mitochondrial function, and sperm DNA integrity all influence how accurately chromosomes are sorted during fertilisation. This is where naturopathic and lifestyle medicine has genuine clinical relevance: not as a replacement for medical investigation, but as a meaningful part of optimising the environment in which conception happens.
IF THE SAME ABNORMALITY KEEPS RECURRING
If, on the other hand, the same chromosomal abnormality keeps recurring across pregnancies, that is a different signal entirely. A recurring structural pattern warrants parental karyotyping (a chromosomal test for both partners) to rule out a balanced translocation or other inherited chromosomal variant passing on as an unbalanced arrangement in the embryo. This is a very different protocol to pursuing egg or sperm quality optimisation, and it is only possible to distinguish the two if the pregnancies have been tested.
IF THE EMBRYO WAS CHROMOSOMALLY NORMAL
A chromosomally normal embryo that miscarried is a different picture again, and in some ways the most important one to identify. A normal embryo that did not continue is not a story about chromosomes at all. It is a question about the environment that embryo was trying to implant into: the uterine lining, immune tolerance, hormonal support in early pregnancy, autoimmune activity, the microbiome, thrombophilia risk. This is where the full maternal and paternal workup becomes not just useful but essential.
THIS TESTING EXISTS AND YOU ARE ENTITLED TO ASK FOR IT
This testing exists. It is available in Australia. It is not experimental. And yet it is rarely offered as routine, particularly after a first or second loss.
I understand the pressures on healthcare systems. Protocols exist for reasons, and resource allocation is genuinely complex. But the couples I see who have experienced two or three miscarriages without a single pregnancy ever being tested: that is a gap with real consequences. Without this information, every subsequent investigation is, to some degree, working in the dark.
If foetal chromosomal testing was not offered or discussed after your loss, you are entitled to ask about it. That conversation is available to you.
A Note on Methylation and MTHFR
The internet has given MTHFR an outsized reputation. It is sometimes held up as the singular explanation for miscarriage, sometimes dismissed entirely as a non-issue. The clinical reality is more nuanced.
MTHFR miscarriage research does not establish a simple cause-and-effect relationship. What MTHFR variants do affect is how efficiently the body processes folate and manages methylation pathways. This has downstream effects on homocysteine levels, on DNA methylation, and on cellular repair. All of these matter in the context of embryo development. For some individuals, this is clinically meaningful. For others, it is not the primary driver.
MTHFR is one piece of the picture. Nutrigenomics (the intersection of genetics and nutrition) is a legitimate clinical lens. It belongs in the conversation, held in proportion, alongside everything else. One finding is never the whole story.
What to Ask Your Healthcare Team
"Was foetal chromosomal testing an option after my miscarriage, and is it something we should consider?"
"Can we look at a full thyroid panel, including antibodies?"
"Has antiphospholipid syndrome been investigated?"
"Has my partner had sperm DNA fragmentation testing?"
"Is there merit in looking at methylation and nutrigenomic factors in my case?"
"Is NK cell activity relevant given my history?"
These are reasonable, evidence-informed questions. A clinician who is genuinely engaged with your care will be willing to have these conversations or to refer you to someone who can.
You Deserve More Than "Keep Trying"
There is a version of post-miscarriage care that is compassionate and thorough. That holds the emotional weight of what has happened while also taking seriously the question of why. That investigates both partners. That does not require three losses before it starts looking.
That version of care exists. It may take some advocating to access.
When I work with couples who have been told their results are normal and there is nothing to find, and we look with more clinical curiosity and a broader lens — often there is something worth finding. Not always a single cause. Not always a definitive answer. But something. A piece of the picture that had been missing.
You are not asking for too much when you want to understand why. That is a legitimate clinical question that deserves a real clinical response.
The investigation of pregnancy loss is not a privilege. It is a conversation every couple deserves to be offered.
Ready to stop guessing and start investigating?
If you'd like to explore what a thorough fertility investigation looks like for you and your partner, I'd love to talk.
Start with a Free Discovery Call and learn how a personalised, science-rooted approach can bring clarity and renewed hope.
The information in this article is for educational purposes only and does not constitute medical advice or replace personalised clinical care. Every person's health picture is unique, and what is appropriate for one individual may not be appropriate for another. If you are navigating fertility challenges, pregnancy loss, or any other health concern, please seek guidance from a qualified health practitioner who can assess your individual circumstances. For individualised assessment and treatment, please consult a qualified health practitioner.
